Sartorius Stedim Biotech (SSB) has entered into a global sales partnership with Umetrics AB, a provider of chemometrics software for modeling and optimizing development and manufacturing processes. SSB will assume global marketing and distribution of Umetrics portfolio for the pharma and biopharma industries. Additionally, SSB will integrate Umetrics software programs as private label products into its own bioprocess portfolio and market the stand-alone solutions under both brands.
Stefan Schlack, senior vice president of marketing at SSB, said, “These software solutions will help our customers to better understand their cell culture processes and to identify potential for optimization and robust process control — an ideal addition to our bioprocess portfolio.”
“With SSB, we can gain access to substantially more customers thanks to its international reach and solid market standing in the biopharma sector. SSB’s integrated solutions for the complete biopharmaceutical process clearly create added value for our customers. I anticipate that this will considerably boost the biopharmaceutical industry’s interest in and usage of our products,” said Lars Lindstorm, general manager of Umetrics.
Sartorius Stedim Biotech Expands PAT Software Portfolio
Published December 18, 2012
blog comments powered by Disqus